NCT00051948 - TLK286 in Combination With Paraplatin (Carboplatin) in Recurrent Ovarian Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

January 31, 2005

Study Completion Date

January 31, 2005

Conditions

Ovarian Neoplasms

Interventions

DRUG

TLK286

Trial Locations (6)

Midwest Cancer Research Group, Inc., Skokie

M.D. Anderson Cancer Center, Houston

Santa Monica Hematology/Oncology Consultants, Santa Monica

Beth Israel Deaconess Medical Center, Boston

Dana Farber Cancer Institute, Boston

Massachusetts General Hospital, Boston